A Study to Evaluate the Efficacy and Safety of 2 Doses of EYE103 Compared With Ranibizumab (0.5 mg) in Participants With DME
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Charles Miller, MD PhD
EyeBiotech Ltd.
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
183 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Buenos Aires, Argentina
CABA, Buenos Aires, Argentina
- Buenos Aires, Argentina
CABA, Buenos Aires, Argentina
- Buenos Aires, Argentina
CABA, Buenos Aires, Argentina
- Caba, Buenos Aires, Argentina
Caba, Buenos Aires, Argentina
- Cordoba, Argentina
Córdoba, Córdoba Province, Argentina
- Santa Fe, Argentina
Rosario, Santa Fe Province, Argentina
- Santa Fe, Argentina
Rosario, Sante Fe, Argentina
- Buenos Aires, Argentina
CABA, Argentina
- Ciudad de Cordoba, Argentina
Córdoba, Argentina
- Sydney Retina Clinic
Sydney, New South Wales, Australia
- Sydney, Australia
Sydney, New South Wales, Australia
- Albury, Australia
Albury, Australia
- Parramatta, Australia
Parramatta, Australia
- Sydney, Australia
Sydney, Australia
- Graz, Austria
Graz, Austria
- Innsbruck, Austria
Innsbruck, Austria
- Vienna, Austria
Vienna, Austria
- Vienna, Austria
Vienna, Austria
- Medellin, Colombia
Medellín, Antioquia, Colombia
- Barranquilla, Colombia
Barranquilla, Atlántico, Colombia
- Bogota, Columbia
Bogotá, Columbia, Colombia
- Cali, Colombia
Cali, Valle del Cauca Department, Colombia
- Medellin, Colombia
Medellín, Colombia
- Osijek, Croatia
Osijek, Croatia
- Mlada Boleslav, Czechia
Mladá Boleslav, Czechia
- Nachod, Czechia
Náchod, Czechia
- Prague, Czechia
Prague, Czechia
- Prague, Czechia
Prague, Czechia
- Cedex, France
Dijon, Cedex, France
- Creteil, France
Créteil, France
- Lyon, France
Lyon, France
- Marseille, France
Marseille, France
- Paris, France
Paris, France
- Paris, France
Paris, France
- Paris, France
Paris, France
- Saint Cyr Sur Loire, France
Saint-Cyr-sur-Loire, France
- Frankfurt, Germany
Frankfurt, Germany
- Hanover, Germany
Hanover, Germany
- Munchen, Germany
München, Germany
- Munster, Germany
Münster, Germany
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 7 Aug 2024
- Primary completion
- 30 Sept 2026
- Completion
- 31 Dec 2027
- Last update posted
- 26 Jun 2026
- Registered enrollment
- 984
- Registry id
- NCT06571045
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.